EE04952B1 - Ravimkoostis ja meetod selle valmistamiseks - Google Patents
Ravimkoostis ja meetod selle valmistamiseksInfo
- Publication number
- EE04952B1 EE04952B1 EEP200200042A EEP200200042A EE04952B1 EE 04952 B1 EE04952 B1 EE 04952B1 EE P200200042 A EEP200200042 A EE P200200042A EE P200200042 A EEP200200042 A EE P200200042A EE 04952 B1 EE04952 B1 EE 04952B1
- Authority
- EE
- Estonia
- Prior art keywords
- pharmaceutical composition
- preparation
- active ingredient
- additional active
- stabilizers
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 abstract 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 1
- OMFNSKIUKYOYRG-MOSHPQCFSA-N drotaverine Chemical compound C1=C(OCC)C(OCC)=CC=C1\C=C/1C2=CC(OCC)=C(OCC)C=C2CCN\1 OMFNSKIUKYOYRG-MOSHPQCFSA-N 0.000 abstract 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 229960005489 paracetamol Drugs 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 229940069338 potassium sorbate Drugs 0.000 abstract 1
- 235000010241 potassium sorbate Nutrition 0.000 abstract 1
- 239000004302 potassium sorbate Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902559A HU225779B1 (en) | 1999-07-28 | 1999-07-28 | Pharmaceutical composition containing paracetamol and drotaverine and process for producing it |
| PCT/HU2000/000086 WO2001007024A2 (en) | 1999-07-28 | 2000-07-28 | Paracetamol and drotaverine containing composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200200042A EE200200042A (et) | 2003-04-15 |
| EE04952B1 true EE04952B1 (et) | 2008-02-15 |
Family
ID=90014235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200042A EE04952B1 (et) | 1999-07-28 | 2000-07-28 | Ravimkoostis ja meetod selle valmistamiseks |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1200088B1 (et) |
| AT (1) | ATE241983T1 (et) |
| AU (1) | AU6308800A (et) |
| BG (1) | BG65553B1 (et) |
| DE (1) | DE60003188T2 (et) |
| DK (1) | DK1200088T3 (et) |
| EA (1) | EA003779B1 (et) |
| EE (1) | EE04952B1 (et) |
| ES (1) | ES2197107T3 (et) |
| GE (1) | GEP20053581B (et) |
| HR (1) | HRP20020071B1 (et) |
| HU (1) | HU225779B1 (et) |
| ME (2) | MEP18508A (et) |
| PL (1) | PL197749B1 (et) |
| PT (1) | PT1200088E (et) |
| RS (1) | RS50074B (et) |
| SI (1) | SI1200088T1 (et) |
| UA (1) | UA72535C2 (et) |
| WO (1) | WO2001007024A2 (et) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY29527A1 (es) | 2005-05-13 | 2006-12-29 | Schering Ag | Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato. |
| RU2704613C2 (ru) * | 2014-11-11 | 2019-10-30 | Д-Р Редди'С Лабораторис Лимитед | Фармацевтические препараты с фиксированной комбинацией доз обезболивающего и антиспазматического агентов |
| EP3520781A1 (en) * | 2018-02-05 | 2019-08-07 | Adamed sp. z o.o. | A pharmaceutical composition comprising metamizole, drotaverine, and caffeine |
| US20230018600A1 (en) | 2020-03-09 | 2023-01-19 | Berlia Sushma Paul | Controlled release formulations comprising drotaverine or salt thereof |
| EP4140480A4 (en) * | 2020-04-23 | 2024-06-12 | Natural Medicine Institute Of Zhejiang Yangshengtang Co., Ltd. | DRUG COMBINATION AND USE |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3830353A1 (de) * | 1988-09-07 | 1990-03-15 | Basf Ag | Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen |
| US5348745A (en) * | 1989-05-09 | 1994-09-20 | Miles Inc. | Aqueous granulation solution and a method of tablet granulation |
-
1999
- 1999-07-28 HU HU9902559A patent/HU225779B1/hu not_active IP Right Cessation
-
2000
- 2000-07-28 PL PL353209A patent/PL197749B1/pl unknown
- 2000-07-28 UA UA2002021475A patent/UA72535C2/uk unknown
- 2000-07-28 WO PCT/HU2000/000086 patent/WO2001007024A2/en active IP Right Grant
- 2000-07-28 GE GE4754A patent/GEP20053581B/en unknown
- 2000-07-28 AT AT00949829T patent/ATE241983T1/de active
- 2000-07-28 EP EP00949829A patent/EP1200088B1/en not_active Expired - Lifetime
- 2000-07-28 DK DK00949829T patent/DK1200088T3/da active
- 2000-07-28 AU AU63088/00A patent/AU6308800A/en not_active Abandoned
- 2000-07-28 EA EA200200211A patent/EA003779B1/ru not_active IP Right Cessation
- 2000-07-28 EE EEP200200042A patent/EE04952B1/et not_active IP Right Cessation
- 2000-07-28 ME MEP-185/08A patent/MEP18508A/xx unknown
- 2000-07-28 RS YUP-61/02A patent/RS50074B/sr unknown
- 2000-07-28 ME MEP-2008-185A patent/ME00088B/me unknown
- 2000-07-28 ES ES00949829T patent/ES2197107T3/es not_active Expired - Lifetime
- 2000-07-28 DE DE60003188T patent/DE60003188T2/de not_active Expired - Lifetime
- 2000-07-28 SI SI200030163T patent/SI1200088T1/xx unknown
- 2000-07-28 PT PT00949829T patent/PT1200088E/pt unknown
-
2002
- 2002-01-25 HR HR20020071A patent/HRP20020071B1/xx not_active IP Right Cessation
- 2002-01-30 BG BG106368A patent/BG65553B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA72535C2 (en) | 2005-03-15 |
| HUP9902559A3 (en) | 2003-05-28 |
| BG65553B1 (bg) | 2008-12-30 |
| HU225779B1 (en) | 2007-08-28 |
| SI1200088T1 (en) | 2003-12-31 |
| DE60003188D1 (de) | 2003-07-10 |
| ATE241983T1 (de) | 2003-06-15 |
| HUP9902559A2 (hu) | 2002-04-29 |
| WO2001007024A3 (en) | 2001-03-29 |
| ES2197107T3 (es) | 2004-01-01 |
| PT1200088E (pt) | 2003-10-31 |
| EA003779B1 (ru) | 2003-08-28 |
| EE200200042A (et) | 2003-04-15 |
| GEP20053581B (en) | 2005-07-25 |
| BG106368A (en) | 2002-08-30 |
| HUP9902559D0 (en) | 1999-10-28 |
| EA200200211A1 (ru) | 2002-08-29 |
| YU6102A (sh) | 2005-03-15 |
| HRP20020071B1 (en) | 2011-01-31 |
| ME00088B (me) | 2010-10-10 |
| DK1200088T3 (da) | 2003-09-22 |
| EP1200088B1 (en) | 2003-06-04 |
| EP1200088A2 (en) | 2002-05-02 |
| RS50074B (sr) | 2009-01-22 |
| AU6308800A (en) | 2001-02-13 |
| PL353209A1 (en) | 2003-11-03 |
| MEP18508A (en) | 2010-06-10 |
| DE60003188T2 (de) | 2004-07-01 |
| WO2001007024A2 (en) | 2001-02-01 |
| PL197749B1 (pl) | 2008-04-30 |
| HRP20020071A2 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME00298B (me) | Farmaceutski preparat | |
| WO2004033418A3 (en) | Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists | |
| TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| EE201000020A (et) | Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja | |
| EA200702594A1 (ru) | Многофункциональные композиции концентрата с высоким содержанием действующего вещества для контроля эктопаразитов | |
| EA200301275A1 (ru) | Капсулы для ингаляции | |
| DK1526839T3 (da) | Orale farmaceutiske former for flydende lægemidler med forbedret biotilgængelighed | |
| WO2004026836A8 (en) | 1-pyridin-4-yl-urea derivatives | |
| BRPI0309651B8 (pt) | método para prevenir ou reduzir a resistência a um pesticida de uma peste de substrato, composição de pesticida, uso dos mesmos, e, método para preparar uma composição de pesticida | |
| MXPA04011990A (es) | Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo. | |
| WO2002015933A3 (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
| EE200200042A (et) | Ravimkoostis ja meetod selle valmistamiseks | |
| BR0013283A (pt) | Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo | |
| EA200500671A1 (ru) | Фармацевтический состав оланзапина | |
| SE0000303D0 (sv) | Novel compounds | |
| WO2004026319A3 (en) | Pharmaceutical compositions increasing camp useful for the treatment of cancers | |
| BR0313076A (pt) | Sal de ácido orgânico de amlodipina | |
| DE60210308D1 (de) | Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure | |
| BR0215352A (pt) | Composição farmacêutica que compreende um inibidor de alfa-glicosidase e um ácido 4-oxobutanóico, e seu uso para tratar diabetes | |
| WO2002002763A3 (en) | Recombinant staphylococcus aureus peptide deformylase | |
| BR0215498A (pt) | Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes | |
| SI1677808T1 (sl) | Kombiniran pripravek za zdravljenje sepse | |
| WO2004075822A3 (fr) | Composition pharmaceutique pour administration transdermique ou transmuqueuse | |
| WO2004105738A3 (en) | Use of tetrahydropyridine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| HC1A | Change of owner name |
Owner name: CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYANRA ZRT |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20170728 |